Announcements
- Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders
- Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives
- Relief Therapeutics has published its Annual Report
- RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
- RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
- Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
More ▼
Key statistics
On Friday, Relief Therapeutics Holding SA (0QKQ:LSE) closed at 1.26, 5.88% above its 52-week low of 1.19, set on May 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 1.26 |
Average volume | 68.89 |
---|---|
Shares outstanding | 14.04m |
Free float | 10.75m |
P/E (TTM) | -- |
Market cap | 17.76m CHF |
EPS (TTM) | -8.45 CHF |
Data delayed at least 20 minutes, as of May 31 2024 16:24 BST.
More ▼